Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125264381 | 12526438 | 1 | I | 20150903 | 20160705 | 20160705 | PER | US-TEVA-592141USA | TEVA | 0.00 | M | Y | 77.18000 | KG | 20160705 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125264381 | 12526438 | 1 | PS | FINASTERIDE. | FINASTERIDE | 1 | 29F109 | 76340 | 5 | MG | TABLET | ||||||||
125264381 | 12526438 | 2 | SS | FINASTERIDE. | FINASTERIDE | 1 | 29F109 | 76340 | |||||||||||
125264381 | 12526438 | 3 | SS | FINASTERIDE. | FINASTERIDE | 1 | 29F109 | 76340 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125264381 | 12526438 | 1 | Benign prostatic hyperplasia |
125264381 | 12526438 | 2 | Benign prostatic hyperplasia |
125264381 | 12526438 | 3 | Bladder obstruction |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125264381 | 12526438 | Benign prostatic hyperplasia | |
125264381 | 12526438 | Drug ineffective | |
125264381 | 12526438 | Dysuria |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125264381 | 12526438 | 1 | 20150323 | 0 |